References
- Digel W., Stefanic M., Schoniger W., Buck C., Raghavachar A., Frickofen N., Heimpel H., Porzsolt F. Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood 1989; 73: 1242–1246
- Cordingley F. T., Biachni A., Hoffbrand A. V. TNF as an autocrine tumor growth factor for chronic B cell malignancies. Lancet 1988; II: 969–971
- Kawano M., Hirano T., Matsuda T. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988; 332: 83–85
- Trinchieri G., Kobayashi M., Rosen M. Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon. J. Exp. Med. 1986; 164: 1206–1255
- Tamm I. IL-6: Current research and new questions. Ann. N. Y. Acad. Sci. 1989; 557: 478–489
- Broxmeyer H. E., Williams D. E., Lu L. The suppressive influences of human tumor necrosis factor on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon γ. J. Immunol. 1986; 136: 4487–4495
- Revel M., Zilberstein A., Chen L. Biological activities of recombinant human IFN-β2/IL-6 (E. coli). Ann. N.Y. Acad. Sci. 1989; 557: 144–156
- Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol. Today 1990; 11: 443–449
- Kawano M., Tanaka H., Ishikawa H. Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma. Blood 1989; 73: 2145–2148
- Kishimoto T., Yoshizaki K., Kimoto M. B cell growth and differentiation factors and mechanism of B cell activation. Immunol. Rev. 1984; 78: 97–118
- Kehrl J. H., Miller A., Fauci A. S. Effect of tumor necrosis factorα on mitogen-activated human B cells. J. Exp. Med. 1987; 166: 786–791
- Biondi A., Rossi V., Bassan R. Constitutive expression of the interleukin 6 gene in chronic lymphocytic leukemia. Blood 1989; 73: 1279–1284
- Hahn T., Kusminsky G., Bassous L., Berrebi A. Tumor necrosis factor production in B cell chronic lymphocytic leukemia. Leukemia and Lymphoma 1991; 4: 117–121
- Uggla C., Aguilar-Santelises Rosen A. Spontaneous production of IL-6 activity by chronic lymphocytic leukemia cells. Blood 1987; 70: 1851–1857
- Foa F., Massaia M., Cordona S. Production of tumor necrosis factor-alpha by B cell chronic lymphocytic leukemia cells: A possible regulatory role of TNF in the progression of the disease. Blood 1990; 76: 393–400
- Rai K. R., Sawitzky A., Cronkite E. P. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
- Nordan R. P., Potter M. A macrophage derived factor required by plasmacytomas for survival and proliferation in vitro. Science 1986; 233: 566–569
- Chen L., Mory Y., Zilberstein A., Revel M. Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon β2. Proc. Natl. Acad. Sci. USA. 1988; 85: 8037–8041
- Carswell E. A., Old L. J., Kassel R. L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 1975; 72: 3666–3670
- Kohase M., Henriksen-DeStefano D., May L. T., Vilcek J., Sehgal P. M. Induction of beta-2 interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation. Cell 1986; 45: 659–666